Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mind Cure Health Inc (MCURF)

Mind Cure Health Inc (MCURF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MCURF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2980 +7.52%
on 04/16/21
0.4000 -19.90%
on 04/12/21
-0.0592 (-15.60%)
since 03/16/21
3-Month
0.2980 +7.52%
on 04/16/21
0.6308 -49.21%
on 01/25/21
-0.2243 (-41.18%)
since 01/15/21

Most Recent Stories

More News
Industry Leaders Look To Artificial Intelligence To Drive Advancements In Mental Healthcare

Prominent mental healthcare conditions including anxiety, depression, and PTSD have historically required ...

MCURF : 0.3204 (-0.53%)
MMEDF : 2.4300 (-0.82%)
NUMI.VN : 0.900 (-2.17%)
LKYSF : 0.7204 (-1.32%)
FTRP.CN : 6.020 (+2.03%)
FTRPF : 4.8218 (+3.37%)
CLXPF : 1.4000 (-3.45%)
MCUR.CN : 0.380 (-7.32%)
MINDCURE Announces The Addition of Daniel Herrera, A Pharmaceutical Industry Executive With Specific Experience in Medical Psychoactive Segment

MINDCURE Announces The Addition of Daniel Herrera, A Pharmaceutical Industry Executive With Specific Experience in Medical Psychoactive Segment

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
MINDCURE Announces Partnership with Speak Ai to Enhance iSTRYM, the Company's Psychedelic Digital Therapeutics Technology Platform

MINDCURE Announces Partnership with Speak Ai to Enhance iSTRYM, the Company's Psychedelic Digital Therapeutics Technology Platform

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors

MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
Emerging Markets Report: The Mushroom Movement

An Emerging Markets Sponsored Commentary

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
Why Mainstream Mental-Health Care is Embracing Psilocybin - Alternative Active Substances

, /PRNewswire/ -- Psychedelic healing may sound like a fad from the Woodstock era, but it's a field of study that's gaining traction in the medical community as an effective treatment option for a growing...

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
MMEDF : 2.4300 (-0.82%)
LKYSF : 0.7204 (-1.32%)
NUMI.VN : 0.900 (-2.17%)
CMPS : 34.35 (+0.94%)
CLXPF : 1.4000 (-3.45%)
MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients

MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners...

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
Emerging Markets Report: A Psychedelic Solution to a National Crisis

An Emerging Markets Sponsored Commentary

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
Psychedelic Drugs Market Ballooning Quickly Due to Increasing Frequency of Mental Disorders

, /PRNewswire/ -- Psychedelic Medicines also called as hallucinogenics, are a group of substances including chemicals, such as LSD, and plants that are used in the treatment of various mental disorders...

MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)
LKYSF : 0.7204 (-1.32%)
NUMI.VN : 0.900 (-2.17%)
MYCOF : 0.2749 (+1.81%)
MYCO.CN : 0.340 (-1.45%)
CMPS : 34.35 (+0.94%)
MMEDF : 2.4300 (-0.82%)
Ty Tashiro joins MINDCURE as the Senior Translational and Psychometric Architect for iSTRYM's AI-Driven Psychedelic Digital Therapeutic Technology

Ty Tashiro joins MINDCURE as the Senior Translational and Psychometric Architect for iSTRYM's AI-Driven Psychedelic Digital Therapeutic Technology

IBM : 133.59 (+0.76%)
MCUR.CN : 0.380 (-7.32%)
MCURF : 0.3204 (-0.53%)

Key Turning Points

3rd Resistance Point 0.3754
2nd Resistance Point 0.3555
1st Resistance Point 0.3379
Last Price 0.3204
1st Support Level 0.3004
2nd Support Level 0.2805
3rd Support Level 0.2629

See More

52-Week High 0.8584
Fibonacci 61.8% 0.6443
Fibonacci 50% 0.5782
Fibonacci 38.2% 0.5121
Last Price 0.3204
52-Week Low 0.2980

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar